Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced Coronary Intervention Inc.

This article was originally published in Start Up

Executive Summary

Surgical Devices; Restenosis. Advanced Coronary Intervention's guided selective atherectomy process combines real-time ultrasound sensors located on a catheter to guide a physician to a blockage. Radio frequency energy then ablates plaque without damaging arterial walls. Key to the system is the ability to modulate radio frequency energy in such a way that it removes thermocoagulation properties.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036953

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel